Neuralink Plans 20,000 Surgical Implants per Year
By Reuters | 23 Jul, 2025
Five clinics implanting three devices will drive $1 billion annual revenues by 2031 according to investor documents released by Elon Musk's Neuralink.
A 3D-printed miniature model of Elon Musk and the Neuralink logo are seen in this illustration taken January 23, 2025. REUTERS/Dado Ruvic/Illustration/File Photo
Elon Musk's brain implant company Neuralink aims to generate at least $1 billion in annual revenue by 2031, driven by plans to perform 20,000 surgeries per year, Bloomberg News reported on Wednesday, citing investor documents.
The company aims to operate five large clinics within six years and offer three versions of its brain device, including Telepathy for communication between the brain and machines, Blindsight for restoring vision, and Deep for treating tremors and Parkinson's disease, according to the report.
Neuralink did not immediately respond to a Reuters request for comment.
The company expects regulatory approval for its Telepathy device by 2029, with plans to perform 2,000 surgeries annually and generate $100 million in revenue, the report said. By 2030, Neuralink anticipates launching Blindsight, expanding surgeries to 10,000 per year and generating over $500 million in revenue.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Anil D'Silva)
Recent Articles
- Jane Fonda to Host First Amendment Celebration Opposite Trump's UFC Event
- SK Hynix Picks Nasdaq for Planned US Listing
- Ukraine's Defense AI Chief Predicts 'New Paradigm' of Warfare
- How Musk's Tactics Blinded Investors to SpaceX Risks
- Baidu, PostBus Get Certified for Robotaxi Service in Eastern Switzerland
- Nvidia Begins Pitching Vera Agentic-AI CPU Sales to Chinese Clients
- Crypto Exchanges Cash in on SpaceX Frenzy with Pre-IPO Derivatives
- Empty World Cup Match Seats Renews Concerns over Ticket Prices
- TSMC Boss's Fear of Shortages of Talent Should Alarm SpaceX Investors
- SpaceX Whets Chinese IPO Appetites but Tech Gap Persists
